Skip to main content
. 2022 Feb 23;13:808370. doi: 10.3389/fphar.2022.808370

FIGURE 1.

FIGURE 1

Italian (A) and Sicilian (B) trend of ADR reports related to drugs approved for MS over the years. ADR, adverse drug reaction; MS, multiple sclerosis.